Search Results - "Flórez Grau, Georgina"
-
1
PGE2‐EP4 signaling steers cDC2 maturation toward the induction of suppressive T‐cell responses
Published in European journal of immunology (01-03-2024)“…Dendritic cells (DCs) shape adaptive immunity in response to environmental cues such as cytokines or lipid mediators, including prostaglandin E2 (PGE2). In…”
Get full text
Journal Article -
2
Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
Published in Frontiers in immunology (31-05-2018)“…The identification of activated T-lymphocytes restricted to myelin-derived immunogenic peptides in multiple sclerosis (MS) and aquaporin-4 water channel in…”
Get full text
Journal Article -
3
Up‐regulation of EP2 and EP3 receptors in human tolerogenic dendritic cells boosts the immunosuppressive activity of PGE2
Published in Journal of leukocyte biology (01-09-2017)“…PGE2 signals via EP2 and EP3 receptors to promote IL‐10 production by tol‐DCs, and potentiate their immunosuppressive properties. Dendritic cells (DCs) are…”
Get full text
Journal Article -
4
Guidelines for mouse and human DC generation
Published in European journal of immunology (01-11-2023)“…This article is part of the Dendritic Cell Guidelines article series, which provides a collection of state-of-the-art protocols for the preparation, phenotype…”
Get full text
Journal Article -
5
Three distinct tolerogenic CD14+ myeloid cell types to actively manage autoimmune disease: Opportunities and challenges
Published in Journal of autoimmunity (01-06-2021)“…Current treatment for patients with autoimmune disorders including rheumatoid arthritis, multiple sclerosis and type 1 diabetes, often consists of long-term…”
Get full text
Journal Article -
6
Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry
Published in European journal of immunology (01-01-2024)“…Dendritic cells (DCs) are essential in antitumor immunity. In humans, three main DC subsets are defined: two types of conventional DCs (cDC1s and cDC2s) and…”
Get full text
Journal Article -
7
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming
Published in European journal of immunology (01-06-2021)“…Dendritic cells (DCs) are key regulators of the immune system that shape T cell responses. Regulation of T cell induction by DCs may occur via the…”
Get full text
Journal Article -
8
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Published in Frontiers in immunology (19-02-2021)“…Immunotherapeutic approaches have revolutionized the treatment of several diseases such as cancer. The main goal of immunotherapy for cancer is to modulate the…”
Get full text
Journal Article -
9
Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination
Published in Cell reports (Cambridge) (28-01-2020)“…Plasmacytoid dendritic cells (pDCs) and type 2 conventional dendritic cells (cDC2s) are currently under evaluation for use in cancer vaccines. Although both DC…”
Get full text
Journal Article -
10
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists
Published in International journal of molecular sciences (11-01-2023)“…Prostaglandin E2 (PGE2) is an important maturation mediator for dendritic cells (DCs). However, increased PGE2 levels in the tumor exert immunosuppressive…”
Get full text
Journal Article -
11
EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells
Published in Frontiers in immunology (2024)“…Tumors educate their environment to prime the occurrence of suppressive cell subsets, which enable tumor evasion and favors tumor progression. Among these,…”
Get full text
Journal Article -
12
Recent Advances and Future Perspective of DC-Based Therapy in NSCLC
Published in Frontiers in immunology (28-06-2021)“…Current treatment for patients with non-small-cell lung cancer (NSCLC) is suboptimal since therapy is only effective in a minority of patients and does not…”
Get full text
Journal Article -
13
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
Published in Oncoimmunology (01-01-2021)“…Cancer immunotherapies have induced long-lasting responses in cancer patients including those with melanoma and head and neck squamous cell carcinoma (HNSCC)…”
Get full text
Journal Article -
14
Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells
Published in Cancer Immunology, Immunotherapy (01-09-2018)“…There has recently been a paradigm shift in the field of dendritic cell (DC)-based immunotherapy, where several clinical studies have confirmed the feasibility…”
Get full text
Journal Article -
15
Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Published in Frontiers in oncology (26-04-2018)“…Diffuse intrinsic pontine glioma (DIPG) is a lethal brainstem tumor in children. Dendritic cells (DCs) have T-cell stimulatory capacity and, therefore,…”
Get full text
Journal Article -
16
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics
Published in Journal of immunology research (01-01-2019)“…The STAT signaling pathway is important in dendritic cell (DC) development and function. Tumor cells can induce STAT signaling, thereby inhibiting DC…”
Get full text
Journal Article -
17
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
Published in Journal for immunotherapy of cancer (01-04-2022)“…BackgroundType 1 conventional dendritic cells (cDC1s) are characterized by their ability to induce potent CD8+ T cell responses. In efforts to generate novel…”
Get full text
Journal Article -
18
Human Dendritic Cell Subset Isolation by Magnetic Bead Sorting: A Protocol to Efficiently Obtain Pure Populations
Published in Bio-protocol (20-10-2023)“…Dendritic cells have been investigated for cell-based immunotherapy for various applications. The low abundance of dendritic cells in blood hampers their…”
Get full text
Journal Article -
19
Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Published in Frontiers in oncology (05-06-2018)“…[This corrects the article on p. 127 in vol. 8, PMID: 29755954.]…”
Get full text
Journal Article -
20
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Published in Proceedings of the National Academy of Sciences - PNAS (23-04-2019)“…There are adaptive T-cell and antibody autoimmune responses to myelin-derived peptides in multiple sclerosis (MS) and to aquaporin-4 (AQP4) in neuromyelitis…”
Get full text
Journal Article